New trials for cancer patients at Sarah Cannon Research Institute

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute, UK, explains that the development of immunotherapies for a variety of cancer types and specific cancer proteins is a very active area of research at Sarah Cannon Research Institute.

Year of Production:
Running Time:
Color/Sound:

2015
01:28
Color/Sound

Comments are closed.